News

Kabam expects 2014 sales to be at least $550 million

Kabam expects 2014 sales to be at least $550 million

Building on its announcement of 2013 sales of $360 million, mobile and PC F2P publisher Kabam now says it expects to see growth of at least 35 percent in 2014.

As a privately-owned company, Kabam doesn't have to reveal its financial numbers.

However, with a rumoured IPO on the cards, it's becoming much more transparent about its business.

And that's the context behind its prediction of 2014 sales of between $550 - $650 million.

Wide base

The company has its own stable of very successful titles, with Kingdoms of Camelot, The Hobbit: Kingdoms of Middle-earth  and Fast & Furious 6: The Game  each generating more than $100 million in sales on mobile.

The company has also been aggressively expanding its publishing operations, notably via its $50 million Worldwide Developer Fund.

This is designed to enable studios in China, Japan and Korea get their games successfully launched into European and North American markets.

To-date, Kabam has invested in 23 developers and 30 games. It expects these to generate over $175 million in revenue during 2014.

Big in Berlin

Providing support for these titles and its own expansion, Kabam has also announced plans to triple its headcount in Europe.

Set up in Berlin with 50 staff to run live operations, localisation, support and QA activities, the now 80-strong outfit is moving to a new location in the city that will provide the space for expansion.

By the end of 2014, Kabam expects to be employing 150 staff, who will cover key marketing such as Germany, France, Spain, Italy, the UK as well as Russia and Turkey.

This is important as this wider European region generates more than 40 percent of Kabam's sales.


Contributing Editor

A Pocket Gamer co-founder, Jon is Contributing Editor at PG.biz which means he acts like a slightly confused uncle who's forgotten where he's left his glasses. As well as letters and cameras, he likes imaginary numbers and legumes.

Comments

No comments
View options
  • Order by latest to oldest
  • Order by oldest to latest
  • Show all replies